Suzhou’s CStone Pharma has been approved to start an Australian Phase I clinical trial of its CDK4/6 inhibitor as a treatment for solid tumor cancers. CS3002 is a selective inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6), a...
Read moreLuye Pharma of Yantai has been approved to start Japan trials of its novel treatment for depression, a serotonin-norepinephrine-dopamine triple reuptake inhibitor (SNDRI) in extended release tablet form. Ansofaxine Hydrochloride ER Tablets...
Read moreAmerican medical machinery firm Thermo Fisher Scientific has agreed to build a new factory in China’s Jiangsu province with a vision of long-term development in the country. The base, located in Suzhou High-Tech Zone, will make disposable...
Read moreIKEA plans to invest CNY10 billion (USD1.41 billion) in the Chinese market to advance its commercial operations and digitization, it announced today at a press briefing in Beijing at which it outlined its strategy for the next three years. This...
Read moreThe Trump administration unveiled a proposal Thursday afternoon that would make it easier for health-care providers to known whether a patient has a history of addiction. The Department of Health and Human Services suggested modifying parts of 42...
Read moreState Farm and Amazon are both looking for ways to provide additional services to seniors, a big and growing demographic. State Farm’s Alexa skill will provide options such as check-ins and suggested social activities to help family members...
Read morePfizer announced it is putting an additional $500 million into the construction of its gene therapy manufacturing site in Sanford, North Carolina. It is planned to support the company’s investment in gene therapy research and development, much...
Read moreSuzhou Innovent Bio in-licensed China rights to a novel treatment for type 2 diabetes from Eli Lilly. In 2015, Innovent and Lilly established a $1 billion collaboration to co-develop several Innovent cancer therapeutics, including its...
Read moreYaoyanshe, a Shanghai on-line AI-based CRO/CMO, raised $42 million in a C funding round led by Eastern Bell Capital and Sequoia China. Founded in 2015, Yaoyanshe offers Trial.Link, a repository of China clinical trial information that connects...
Read moreBYD has made it to Fortune’s Change the World List for the first time, claiming third place, as the Chinese electric carmaker expands its social impact to create a cleaner future of driving. BYD, originally a phone battery maker, produced...
Read moreGoldman Sachs Group has applied to the China Securities Regulatory Commission to raise its shareholding in its securities joint venture Goldman Sachs Gao Hua Securities to 51 percent, a company spokesman confirmed to Yicai Global yesterday. The...
Read morePresident Trump speaks with Apple CEO Tim Cook because he calls him personally rather than hiring consultants to do so, Trump told reporters on Wednesday. Trump also referenced the recent conversation he had with Cook about how the tariffs on...
Read more
